During the past decade, Monroe Karetzky, M.D. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Monroe Karetzky, M.D." are "Narcolepsy" (2 trials) and "Sleep Apnea, Obstructive" (2 trials). Many other conditions were trialed in "Monroe Karetzky, M.D." in a lesser frequency.

Most popular intervention types in "Monroe Karetzky, M.D." are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Modafinil" (3 trials). Other intervention names were less common.

The vast majority of trials in "Monroe Karetzky, M.D." are 3 trials for "All" genders.

Currently, there are NaN active trials in "Monroe Karetzky, M.D.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Monroe Karetzky, M.D., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Monroe Karetzky, M.D., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Monroe Karetzky, M.D. has several departments that took part in Clinical trials: "Rutgers Cancer Institute of New Jersey,99 Highway 37 West" - 2 trials